
BLS Pharmaceuticals has rapidly transformed into a profitable regulated-medicines manufacturer, supported by strong revenue growth, controlled-substance licences and international expansion. While FY26 guidance remains ambitious, bearish RSI divergence suggests traders should monitor key support levels closely.

Larvotto Resources Limited (ASX: LRV) is an Australian emerging mining company transitioning from explorer to near-term producer. Its flagship asset, the Hillgrove Antimony–Gold Project in New South Wales, positions the company as a potential supplier of two strategically important metals: gold—a monetary safe-haven—and antimony, a critical mineral used in batteries, semiconductors, and defense alloys.
.webp&w=828&q=75)
TechnologyOne (ASX: TNE) delivers record profit and ARR growth, leveraging its AI‑enabled SaaS+ platform to deepen margins, sustain cash generation, and reinforce its position as Australia’s premier enterprise software provider.

West African Resources (ASX: WAF) delivers record quarterly gold output, strong cash generation, and expanding reserves, reinforcing its position as West Africa’s leading unhedged mid‑tier gold producer with a clear path to 500 koz pas from 2027.
.webp&w=828&q=75)
Benz Mining Corp (ASX: BNZ) advances its Glenburgh Gold Project toward resource definition, delivering high‑grade intercepts, strong funding, and district‑scale potential that positions it as one of Australia’s most aggressive gold growth stories.
.webp&w=828&q=75)
Steadfast Group (ASX: SDF) delivers double‑digit EBITA growth, disciplined acquisitions, and margin expansion across Australasian and international operations, reinforcing its status as a resilient blue‑chip compounder.
...